Drug intelligence / Profile preview

sunbanghwalmyung-eum

Development stage
Preclinical
Administration
Oral
01

Overview

Sunbanghwalmyung-eum (SBH), also known as Xian-Fang-Huo-Ming-Yin in Traditional Chinese Medicine and Seonbanghwalmyeong-eum in Traditional Korean Medicine, is a multi-component herbal medicine traditionally used for its antioxidant, anti-inflammatory, and anticancer properties. Recent preclinical research has demonstrated its potential as a therapeutic agent for obesity and metabolic disorders. SBH exerts systemic anti-obesity effects by downregulating adipogenic transcription factors, including peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT/enhancer-binding protein alpha (C/EBPα), in liver, adipose, and muscle tissues. Furthermore, it activates the AMP-activated protein kinase (AMPK) pathway and hormone-sensitive lipase (HSL), promoting lipolysis and improving plasma lipid profiles (triglycerides, total cholesterol, and LDL-c). SBH also attenuates obesity-related chronic inflammation by inhibiting the expression of pro-inflammatory cytokines such as interleukin-1β (IL-1β), tumor necrosis factor alpha (TNFα), and monocyte chemoattractant protein 1 (MCP1).

Other names
Seonbanghwalmyeong-eumXian-Fang-Huo-Ming-YinSBH
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)CEBPA (CCAAT enhancer-binding protein alpha)LIPE (Hormone-sensitive lipase)AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on sunbanghwalmyung-eum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sunbanghwalmyung-eum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call